Lifestyle adjustment, in combination with symptomatic pharmacologic treatment, allows most patients, particularly those with an inability to stay awake during the day, to live a relatively normal life. New pharmacologic substances show encouraging results in phase 2 and 3 studies to improve the current situation. More dedicated studies in IH, particularly in those who suffer from an increased need for sleep, are needed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jsmc.2022.06.005 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!